Alan Meeker: The Texan Behind Polo’s Genetic Revolution
Alan Meeker, a businessman from Texas with a background in oil and real estate, became one of the most controversial figures in modern polo after venturing into the world of horse cloning. His partnership with Argentine polo legend Adolfo Cambiaso marked a turning point in the sport, blending biotechnology with elite competition.
In 2009, Meeker and Cambiaso signed an agreement to clone some of Cambiaso’s most prized horses, including the legendary mare Cuartetera. Through Meeker’s company, Crestview Genetics, the project produced multiple clones that would go on to compete at the highest levels of polo. The most iconic moment came when Cambiaso won the Argentine Open riding six clones of Cuartetera, a feat that stunned the polo world and validated the potential of cloning in sport.
However, the partnership unraveled in dramatic fashion. Cambiaso accused Meeker of breaching their agreement by selling cloned horses to third parties without authorization. Legal battles ensued in U.S. courts, with Cambiaso seeking to reclaim genetic material and prevent further unauthorized cloning. Meeker, in turn, argued that his company had the contractual right to sell the clones, citing differences between the original 2009 agreement and a later 2019 contract signed under a different entity.
The dispute raised ethical and commercial questions about the future of horse cloning in polo. Cambiaso warned that unrestricted sales of clones could irreparably damage the sport’s competitive balance and dilute the uniqueness of elite bloodlines. The controversy also touched personal chords, involving family members and longtime allies of both parties.
In 2024, a U.S. jury ruled in favor of Cambiaso and La Dolfina, affirming their ownership of Cuartetera’s genetics and ordering the return of all cloned horses and related material. The verdict was seen as a landmark decision in the intersection of sports, science, and intellectual property.